Offer - Urjas Oil for just ₹ 1 X
Megaplat 50 Injection is a prescription drug, available for use as Injection. It is typically used for the treatment of Colorectal Cancer. Secondary and off-label uses of Megaplat 50 Injection have also been mentioned below.
The right dosage of Megaplat 50 Injection depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Some other side effects of Megaplat 50 Injection have been listed ahead. These side effects of Megaplat 50 Injection are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Megaplat 50 Injection's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Megaplat 50 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Megaplat 50 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Arrhythmia are examples of such conditions. Other contraindications of Megaplat 50 Injection have been discussed in the sections ahead.
Additionally, Megaplat 50 Injection may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Megaplat 50 Injection is not safe while driving, and is is not addictive in nature.
Megaplat 50 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Megaplat 50 Injection safe for pregnant women?
Megaplat has many dangerous side effects in pregnant women. If you are pregnant, do not consume Megaplat without medical advice.
Is the use of Megaplat 50 Injection safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Megaplat. It should only be taken after medical advice.
What is the effect of Megaplat 50 Injection on the Kidneys?
Megaplat may have mild side effects on the kidneys.
What is the effect of Megaplat 50 Injection on the Liver?
Megaplat can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Megaplat 50 Injection on the Heart?
The heart can be affected by Megaplat. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Megaplat 50 Injection unless your doctor advises you to do so -
Is this Megaplat 50 Injection habit forming or addictive?
Forming a habit of Megaplat 50 Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Megaplat 50 Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Megaplat 50 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Megaplat 50 Injection cannot treat any kind of mental disorder.
Interaction between Food and Megaplat 50 Injection
You can take Megaplat 50 Injection with food.
Interaction between Alcohol and Megaplat 50 Injection
Taking alcohol with Megaplat 50 Injection can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 954-956
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Eloxatin (oxaliplatin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Oxaliplan™ (oxaliplatin)